Health
FDA Approves Treatment for Chronic Kidney Disease – StreetInsider.com
SILVER SPRING, Md., April 30, 2021 /PRNewswire/ –Â Today, the U.S. Food and Drug Administration approved Farxiga (dapagliflozin) oral tablets to reduce the…
SILVER SPRING, Md., April 30, 2021 /PRNewswire/ – Today, the U.S. Food and Drug Administration approved Farxiga (dapagliflozin) oral tablets to reduce the risk of kidney function decline, kidney failure, cardiovascular death and hospitalization for heart failure in adults with chronic kidney disease who are at risk of disease progression. Â
“Chronic kidney disease is an important public health issue, and there is a significant unmet need for therapies that slow disease progression and improve…
-
Business21 hours agoWhy Vault Minerals, Droneshield, Westgold Resources shares are climbing higher today
-
Noosa News16 hours agoRacing Queensland responds to criticism of ‘deadliest’ greyhound track
-
General20 hours agoTrump’s AUKUS review coming soon. Will he stop the folly?
-
Noosa News21 hours agoQueensland’s nurses and midwives ramp up industrial action as pay negotiations break down